These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8781584)

  • 1. Mutagenicity of anticancer drugs in mammalian germ cells.
    Witt KL; Bishop JB
    Mutat Res; 1996 Aug; 355(1-2):209-34. PubMed ID: 8781584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant lethal and heritable translocation tests with chlorambucil and melphalan in male mice.
    Generoso WM; Witt KL; Cain KT; Hughes L; Cacheiro NL; Lockhart AM; Shelby MD
    Mutat Res; 1995 Dec; 345(3-4):167-80. PubMed ID: 8552138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin, unlike other male-mouse mutagens, is most effective in spermatogonia, inducing primarily deletions.
    Russell LB; Hunsicker PR; Kerley MK; Johnson DK; Shelby MD
    Mutat Res; 2000 Aug; 469(1):95-105. PubMed ID: 10946246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measurement of induced genetic change in mammalian germ cells.
    Adler ID; Pacchierotti F; Russo A
    Methods Mol Biol; 2012; 817():335-75. PubMed ID: 22147580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorambucil and bleomycin induce mutations in the specific-locus test in female mice.
    Russell LB; Hunsicker PR; Shelby MD
    Mutat Res; 1996 Oct; 358(1):25-35. PubMed ID: 8921974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian germ cell mutagenicity of ENU, IPMS and MMS, chemicals selected for a transgenic mouse collaborative study.
    Shelby MD; Tindall KR
    Mutat Res; 1997 Feb; 388(2-3):99-109. PubMed ID: 9057870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlike other chemicals, etoposide (a topoisomerase-II inhibitor) produces peak mutagenicity in primary spermatocytes of the mouse.
    Russell LB; Hunsicker PR; Johnson DK; Shelby MD
    Mutat Res; 1998 May; 400(1-2):279-86. PubMed ID: 9685680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ cell mutagenicity of topoisomerase I inhibitor topotecan detected in the male mouse-dominant lethal study.
    Attia SM; Ahmad SF; Abd-Ellah MF; Hamada FM; Bakheet SA
    Food Chem Toxicol; 2013 Dec; 62():470-4. PubMed ID: 24036143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward an understanding of the use of transgenic mice for the detection of gene mutations in germ cells.
    Douglas GR; Gingerich JD; Soper LM; Jiao J
    Mutat Res; 1997 Feb; 388(2-3):197-212. PubMed ID: 9057881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of specific-locus and dominant lethal mutations in male mice by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Ehling UH; Adler ID; Favor J; Neuhäuser-Klaus A
    Mutat Res; 1997 Oct; 379(2):219-31. PubMed ID: 9357551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of germ-cell mutagens and nonmutagens in the rat spermatocyte UDS assay.
    Bentley KS; Working PK
    Mutat Res; 1988 Apr; 203(2):135-42. PubMed ID: 3352642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Wyrobek AJ; Gordon LA; Burkhart JG; Francis MW; Kapp RW; Letz G; Malling HV; Topham JC; Whorton MD
    Mutat Res; 1983 May; 115(1):1-72. PubMed ID: 6835246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of Ascaris chymotrypsin inhibitor in germ cells of mice.
    Blaszkowska J
    Cell Biol Toxicol; 2008 Jun; 24(3):213-24. PubMed ID: 17674131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-mammal mutagenicity tests: evaluation of five methods.
    Russell LB; Matter BE
    Mutat Res; 1980 May; 75(3):279-302. PubMed ID: 6991917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1994 May; 307(1):229-36. PubMed ID: 7513801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of specific-locus and dominant lethal mutations in male mice by ifosfamide (Holoxan).
    Ehling UH; Favor J; Neuhäuser-Klaus A; Adler ID
    Genet Res; 1998 Dec; 72(3):177-83. PubMed ID: 10036972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlornaphazine and chlorambucil induce dominant lethal mutations in male mice.
    Barnett LB; Lewis SE
    Mutat Res; 2003 Mar; 543(2):145-54. PubMed ID: 12644184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic effects of 1,3-butadiene and associated risk for heritable damage.
    Pacchierotti F; Adler ID; Anderson D; Brinkworth M; Demopoulos NA; Lähdetie J; Osterman-Golkar S; Peltonen K; Russo A; Tates A; Waters R
    Mutat Res; 1998 Jan; 397(1):93-115. PubMed ID: 9463556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.